pancreatic adenocarcinoma
FDA approves Ipsen’s Onivyde for pancreatic adenocarcinoma treatment
February 14, 2024Medical Communications FDA, Oncology, Onivyde, ipsen, pancreatic adenocarcinoma
Ipsen has announced that the US Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) for …
Latest content
Dermatology leader Doncker is new Onicor CEO
October 29, 2026
October 28, 2026
